Table 1 Demographic and clinico-pathological characteristic of the study population
From: Screening of BRCA1/2 variants in Mauritanian breast cancer patients
Parameters | Patients (137) | Percentage (%) |
|---|---|---|
Total of patients | 137 | |
Females | 132 | 96.35 |
Males | 5 | 3.65 |
Age at diagnosis (years) | Mean age Women 45 Men 67 | |
< 35 | 22 | 16.06 |
[35–55] | 95 | 69.34 |
> 55 | 20 | 14.60 |
Familyhistory | ||
Present | 41 | 29.93 |
Absent | 96 | 70.07 |
Consanguinity | ||
Yes | 63 | 45.99 |
Non | 74 | 54.01 |
Ethnicity | ||
White Moors | 73 | 53.28 |
Black Moors | 45 | 32.85 |
Black Africans | 19 | 13.87 |
Histological grading | ||
Grade I | 12 | 8.6 |
Grade II | 80 | 58.39 |
Grade III | 45 | 32.85 |
Staging | ||
Stage I | 2 | 1.46 |
Stage II | 42 | 30.66 |
Stage III | 61 | 44.53 |
Stage IV | 32 | 23.36 |
Histological type | ||
Invasive Ductal Carcinoma (IDC) | 114 | 83.21 |
Invasive Lobular Carcinoma (ILC) | 12 | 8.75 |
11 | 8.04 | |
Immunohistochemistry (N = 96) | ||
TNBC | 45 | 46.87 |
NTNB | 51 | 53.13 |